Harmony Biosciences Holdings, Inc. (HRMY) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.15B |
| Enterprise Value | 1.64B |
| P/E Ratio | 12.19 |
| PEG Ratio | -9.66 |
| Price/Sales Ratio | 2.3 |
| Price/Book Ratio | 2.21 |
| Enterprise/Revenue | 1.89 |
| Enterprise/EBITDA | 6.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.19 |
| Operating Margin | 0.24 |
| Return On Assets | 0.13 |
| Return On Equity | 0.2 |
| Revenue | 868.45M |
| Revenue/Share | 16.59 |
| Gross Profit | 670.11M |
| EBITDA | 255.05M |
| Net Income | 158.69M |
| Diluted EPS | 2.71 |
| Total Cash | 667.79M |
| Total Cash/Share | 11.54 |
| Total Debt | 153.96M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 3.48 |
| Book Value Per Share | 17.27 |
| 52-Week Change | 0.77 |
| 52-Week High | 40.87 |
| 52-Week Low | 25.52 |
| Moving Average 50 Days | 36.3 |
| Moving Average 200 Days | 33.84 |
| Average Volume | 832,812 |
| Shares Outstanding | 57.89M |
| % Held by Institutions | 94.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |